 NEW YORK, April 21, 2021 GLOBE NEWSWIRE -- Royalty Pharma plc Nasdaq: RPRX today announced a collaboration with MSCI Inc. NYSE: MSCI, a leading provider of critical decision support tools and services for the global investment community, to expand MSCIs thematic index suite with the launch of new indexes that aim to capture long-term, cutting edge themes that will disrupt the life sciences, biotechnology and pharmaceutical industry groups. 